Author: Emily K. Mantlo; Natalya Bukreyeva; Junki Maruyama; Slobodan Paessler; Cheng Huang
Title: Potent Antiviral Activities of Type I Interferons to SARS-CoV-2 Infection Document date: 2020_4_5
ID: kb3z3b8f_9
Snippet: Additionally, virus infection caused strong cytopathic effect (CPE), which was evident at 48 hpi, much later than 05 the peak of virus production (at 40 hpi). The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.04.02.022764 doi: bioRxiv preprint returned, and cells were incubated for a further 22 hours. Supernatants were then collected, and viral titers 11 were determined via TCID50 assay. Th.....
Document: Additionally, virus infection caused strong cytopathic effect (CPE), which was evident at 48 hpi, much later than 05 the peak of virus production (at 40 hpi). The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.04.02.022764 doi: bioRxiv preprint returned, and cells were incubated for a further 22 hours. Supernatants were then collected, and viral titers 11 were determined via TCID50 assay. The result indicated that IFN-ï¡ treatment potently inhibited SARS-CoV-2 12 infection. Virus titers were not detectable except at the lowest concentration tested (50 IU/ml), at which the viral 13 titers were drastically reduced by 4 logs of magnitude (Fig. 2) . For IFN-β, the virus titers were below the 14 detection limit at all concentrations tested (50 u/ml-1000u/ml), indicating more potent anti-SARS-CoV-2 activity 15 than IFN-α. Consistently, no CPE was observable under microscopic examination in all IFN-treated samples.
Search related documents:
Co phrase search for related documents- anti sars activity and low concentration: 1, 2, 3, 4
- anti sars activity and viral titer: 1
- anti sars activity and virus infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- anti sars activity and virus production: 1, 2
- anti sars activity and virus titer: 1
- anti sars and cytopathic effect: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- anti sars and detection limit: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- anti sars and low concentration: 1, 2, 3, 4, 5, 6, 7, 8, 9
- anti sars and microscopic examination: 1
- anti sars and viral titer: 1, 2, 3, 4, 5, 6, 7
- anti sars and virus infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- anti sars and virus production: 1, 2, 3, 4, 5, 6
- anti sars and virus titer: 1, 2, 3, 4, 5, 6
- cytopathic effect and microscopic examination: 1, 2, 3
- cytopathic effect and strong cytopathic effect: 1, 2, 3, 4
- cytopathic effect and viral titer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- cytopathic effect and virus infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cytopathic effect and virus production: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- cytopathic effect and virus titer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
Co phrase search for related documents, hyperlinks ordered by date